109 related articles for article (PubMed ID: 45128)
1. Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations.
Calil HM; Avery DH; Hollister LE; Creese I; Snyder SH
Psychiatry Res; 1979 Jul; 1(1):39-44. PubMed ID: 45128
[TBL] [Abstract][Full Text] [Related]
2. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
Kucharski LT; Alexander P; Tune L; Coyle J
Psychopharmacology (Berl); 1984; 82(3):194-8. PubMed ID: 6144127
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol.
Odou P; Vaiva G; Luyckx M; Brunet C; Dine T; Gressier B; Cazin M; Cazin JC
Eur J Clin Pharmacol; 1996; 50(5):357-63. PubMed ID: 8839656
[TBL] [Abstract][Full Text] [Related]
4. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
Krska J; Sampath G; Shah A; Soni SD
Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
[TBL] [Abstract][Full Text] [Related]
6. Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.
Rao ML
Psychopharmacology (Berl); 1986; 90(4):548-53. PubMed ID: 2880364
[TBL] [Abstract][Full Text] [Related]
7. A radioreceptor assay for neuroleptic drugs in plasma.
Lader SR
J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242
[TBL] [Abstract][Full Text] [Related]
8. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG
Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
[TBL] [Abstract][Full Text] [Related]
9. Plasma level monitoring of antipsychotic drugs. Clinical utility.
Dahl SG
Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
[TBL] [Abstract][Full Text] [Related]
10. Serum haloperidol and neuroleptic receptor levels in chronic psychosis.
Cannon DJ; McMillan DE; Newton JE; Fody EP; Metzer WS; Claybrook M; Couch L; Paige SR
Ann Clin Lab Sci; 1988; 18(5):378-83. PubMed ID: 3178137
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine : A Review of its Use in Schizophrenia.
Gunasekara NS; Spencer CM
CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
Ulrich S; Neuhof S; Braun V; Meyer FP
Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
[TBL] [Abstract][Full Text] [Related]
13. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
14. Influence of blood sampling methods on dopamine-receptor-blocking activities as determined by a radioreceptor assay.
Lai AA; Fleck RJ; Patzke JV; Glueck BG; Shaskan EG; Rosenberg BJ
Ther Drug Monit; 1982; 4(1):89-93. PubMed ID: 6122295
[TBL] [Abstract][Full Text] [Related]
15. Blood to brain distribution of neuroleptics.
Sunderland T; Cohen BM
Psychiatry Res; 1987 Apr; 20(4):299-305. PubMed ID: 2885876
[TBL] [Abstract][Full Text] [Related]
16. Study of the clinical utility of radioreceptor assay in outpatients with schizophrenia receiving high doses of neuroleptics.
Gagné MA; Cormier H; Leblanc G; Lévesque D; Di Paolo T
Can J Psychiatry; 1993 Oct; 38(8):534-40. PubMed ID: 7902199
[TBL] [Abstract][Full Text] [Related]
17. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
Cohen BM; Lipinski JF; Waternaux C
Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
[TBL] [Abstract][Full Text] [Related]
18. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.
Ko GN; Korpi ER; Linnoila M
J Clin Psychopharmacol; 1985 Oct; 5(5):253-62. PubMed ID: 2864357
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
20. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
